InteRNA Joins RNA Silencing Research Consortium | GenomeWeb
NEW YORK (GenomeWeb News) – Dutch firm InteRNA Technologies today said that it has joined the SIROCCO research consortium, a group of 25 labs and companies from 10 countries studying the use of RNA silencing for therapeutic applications, such as treating cancer.
 
SIROCCO stands for “Silencing RNAs: organizers and coordinators of complexity in eukaryotic organisms.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.